This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Aug;366(9485):526-7.

doi: 10.1016/S0140-6736(05)67076-6.

Immunohistopathology to guide multiple sclerosis treatment

Ghislain Opdenakker¹

Affiliations

PMID: 16099274
DOI: 10.1016/S0140-6736(05)67076-6

Comment

Immunohistopathology to guide multiple sclerosis treatment

Ghislain Opdenakker. Lancet. 2005 Aug.

. 2005 Aug;366(9485):526-7.

doi: 10.1016/S0140-6736(05)67076-6.

Author

Ghislain Opdenakker¹

Affiliation

¹ Immunobiology, Rega Institute for Medical Research, University of Leuven, B-3000 Leuven, Belgium. ghislain.opdenakker@rega.kuleuven.ac.be

PMID: 16099274
DOI: 10.1016/S0140-6736(05)67076-6

No abstract available

PubMed Disclaimer

Comment on

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange.
Keegan M, König F, McClelland R, Brück W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF. Keegan M, et al. Lancet. 2005 Aug 13-19;366(9485):579-82. doi: 10.1016/S0140-6736(05)67102-4. Lancet. 2005. PMID: 16099294

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

651/MSS_/Multiple Sclerosis Society/United Kingdom

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information